Prostate cancer ultrasound: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) |
Shanshan Cen (talk | contribs) |
||
| Line 10: | Line 10: | ||
::* Small hypoechoic areas (<0.2 cm<sup>3</sup>) have [[cancer]] less than 4% of the time | ::* Small hypoechoic areas (<0.2 cm<sup>3</sup>) have [[cancer]] less than 4% of the time | ||
* [[Transrectal ultrasonography]] (TRUS) is often initially performed in order to detect abnormalities and to guide [[biopsy]], usually following an abnormal [[prostate-specific antigen]] (PSA) level or [[Digital rectal examination]] (DRE) result.<ref name=radio> Prostatic carcinoma.Dr Ian Bickle and Dr Saqba Farooq et al. Radiopaedia.org 2015.http://radiopaedia.org/articles/prostatic-carcinoma-1</ref> | * [[Transrectal ultrasonography]] (TRUS) is often initially performed in order to detect abnormalities and to guide [[biopsy]], usually following an abnormal [[prostate-specific antigen]] (PSA) level or [[Digital rectal examination]] (DRE) result.<ref name=radio> Prostatic carcinoma.Dr Ian Bickle and Dr Saqba Farooq et al. Radiopaedia.org 2015.http://radiopaedia.org/articles/prostatic-carcinoma-1</ref> | ||
* Transrectal [[ultrasound]] is also the modality of choice for directing [[brachytherapy]] seeds into the prostate [[gland]]. | * Transrectal [[ultrasound]] is also the modality of choice for directing [[brachytherapy]] seeds into the prostate [[gland]]. | ||
Revision as of 14:40, 21 September 2015
|
Prostate cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Prostate cancer ultrasound On the Web |
|
American Roentgen Ray Society Images of Prostate cancer ultrasound |
|
Risk calculators and risk factors for Prostate cancer ultrasound |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
On ultrasound, prostate cancer is characterized by hypoechoic areas.
Ultrasound
- On ultrasound, prostate cancer is characterized by hypoechoic areas[1]
- It seems that size of the area matters
- Small hypoechoic areas (<0.2 cm3) have cancer less than 4% of the time
- Transrectal ultrasonography (TRUS) is often initially performed in order to detect abnormalities and to guide biopsy, usually following an abnormal prostate-specific antigen (PSA) level or Digital rectal examination (DRE) result.[2]
- Transrectal ultrasound is also the modality of choice for directing brachytherapy seeds into the prostate gland.
References
- ↑ Prostate cancer. Libre Pathology. http://librepathology.org/wiki/index.php/Prostate_cancer#Gross
- ↑ Prostatic carcinoma.Dr Ian Bickle and Dr Saqba Farooq et al. Radiopaedia.org 2015.http://radiopaedia.org/articles/prostatic-carcinoma-1